European Innovation Council

Photon IP is a deeptech startup located in Eindhoven, the Netherlands, focused on developing advanced technologies for photonics applications. The company specializes in application-specific semiconductors that cater to various sectors, including wearable electronics and data centers. By providing innovative solutions, Photon IP supports clients in industries such as automotive and telecommunications, aiming to enhance the functionality and efficiency of their products.

Mistikist is an AI-driven mental wellbeing platform designed to alleviate stress and enhance focus through personalized audio-visual brainwave entrainment. By leveraging advanced neuroscience, machine learning, and real-time biometrics, Mistikist customizes each session to meet individual user needs, delivering noticeable results in a short time. The platform caters to both business and consumer markets, offering subscription-based services for individuals and enterprise licensing for organizations. Users can access Mistikist through mobile applications, virtual reality headsets, and wearable devices, making it adaptable to busy lifestyles. The application employs audio and visual stimuli, such as binaural beats and kaleidoscope imagery, to influence brainwave activity, promoting relaxation, focus, and improved sleep without the use of medication.

Afon Technology specializes in developing non-invasive blood glucose monitoring devices aimed at improving the management of diabetes. Their innovative technology allows users to convert any smartwatch into a glucose monitoring device that provides real-time tracking of blood glucose levels, including high and low alerts. The devices offer fast and accurate measurements, data logging, and personalized health trend analysis, which help users monitor their condition effectively. Additionally, Afon Technology's solutions feature Bluetooth connectivity to smart devices, enabling compatibility with both iOS and Android platforms. This user-friendly approach enhances the quality of daily diabetes management and helps reduce the risk of complications associated with the condition.

Restore Medical is a medical device company focused on treating congestive heart failure, specifically targeting patients with left ventricle failure. Founded in 2016 and based in Or Yehuda, Israel, the company offers ContraBand, a catheter-delivered implant designed for placement in the pulmonary arteries. This innovative device aims to enhance left ventricle ejection fraction, decrease mitral regurgitation, and restore favorable ventricular geometry. By improving patient outcomes, Restore Medical's solutions contribute to a better quality of life and aim to reduce the rates of hospital readmission among affected individuals.

Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

PKVitality is a bio-wearable company based in Paris, France, that specializes in developing innovative health monitoring devices. Its flagship product, K'Watch Glucose, is a smartwatch-style continuous glucose monitoring device that employs a micro-needle sensor to allow diabetics to monitor their glucose levels painlessly and discreetly. This wearable tracker is designed to provide real-time data without the need for calibration, offering a complete history of glucose levels and sending alerts for potential hypo or hyperglycemia episodes. Additionally, PKVitality is expanding its product line to include a Continuous Lactate Monitor and multi-analyte continuous monitors, which will further enhance the capabilities of their health monitoring technology. Founded in 2017, PKVitality aims to simplify health management for individuals, particularly those with diabetes, by eliminating the discomfort associated with traditional blood tests.

GlucoModicum is a company that specializes in developing innovative technology for needle-free health and biomarker monitoring. It focuses on creating a glucose monitoring solution that utilizes precise magnetohydrodynamic technology. The company is working on wristwear equipped with a replaceable sensor that allows users to monitor their blood glucose levels without the need for needles. This system enables diabetic patients to easily track their health by syncing data with smartphones and uploading it to the cloud, facilitating effective self-management of blood glucose levels.

GlucoModicum is a company that specializes in developing innovative technology for needle-free health and biomarker monitoring. It focuses on creating a glucose monitoring solution that utilizes precise magnetohydrodynamic technology. The company is working on wristwear equipped with a replaceable sensor that allows users to monitor their blood glucose levels without the need for needles. This system enables diabetic patients to easily track their health by syncing data with smartphones and uploading it to the cloud, facilitating effective self-management of blood glucose levels.

Tribute Brand is a high-end digital fashion and technology company recognized as a pioneer in the industry, specializing in contactless and cyber aesthetics. The brand operates a virtual marketplace for non-fungible token (NFT) clothing, providing consumers with access to digital fashion garments designed to promote sustainable practices. By focusing on digital clothing, Tribute Brand aims to reduce the societal impact of traditional fashion, encouraging a shift in consumer behavior towards sustainability. This innovative approach seeks to minimize waste, eliminate sizing restrictions, and challenge gender stereotypes in clothing, thereby transforming the way fashion is perceived and consumed.

Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, established in 2016. It specializes in developing advanced wearable technology for real-time hydration monitoring, which is essential in various sectors, including healthcare, defense, and workforce safety. The company's flagship product, Re:Balans®, offers continuous and non-invasive tracking of fluid balance, allowing for early intervention in hydration-related issues. By integrating with existing remote patient monitoring systems, Mode Sensors supports a range of applications in hospitals, elderly care, military settings, and high-performance work environments. With a commitment to innovation and user-friendly design, Mode Sensors aims to enhance well-being and performance through effective hydration management.

Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, established in 2016. It specializes in developing advanced wearable technology for real-time hydration monitoring, which is essential in various sectors, including healthcare, defense, and workforce safety. The company's flagship product, Re:Balans®, offers continuous and non-invasive tracking of fluid balance, allowing for early intervention in hydration-related issues. By integrating with existing remote patient monitoring systems, Mode Sensors supports a range of applications in hospitals, elderly care, military settings, and high-performance work environments. With a commitment to innovation and user-friendly design, Mode Sensors aims to enhance well-being and performance through effective hydration management.

Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

PKVitality is a bio-wearable company based in Paris, France, that specializes in developing innovative health monitoring devices. Its flagship product, K'Watch Glucose, is a smartwatch-style continuous glucose monitoring device that employs a micro-needle sensor to allow diabetics to monitor their glucose levels painlessly and discreetly. This wearable tracker is designed to provide real-time data without the need for calibration, offering a complete history of glucose levels and sending alerts for potential hypo or hyperglycemia episodes. Additionally, PKVitality is expanding its product line to include a Continuous Lactate Monitor and multi-analyte continuous monitors, which will further enhance the capabilities of their health monitoring technology. Founded in 2017, PKVitality aims to simplify health management for individuals, particularly those with diabetes, by eliminating the discomfort associated with traditional blood tests.